About isatuximab
CD38-targeted monoclonal antibody
Used for
- Treats multiple myeloma with other cancer medicines in adults.
Usual adult dose
10 mg/kg by intravenous infusion, with partner medicines; schedules vary by treatment regimen.
Common side effects
- Infusion reactions
- Pneumonia and other infections
- Diarrhea or nausea
- Low blood-cell counts
Important warnings
- Serious, sometimes fatal infections can occur.
- Infusion reactions may be severe; monitoring and premedication are required.
- May interfere with blood compatibility testing; notify the blood bank before transfusion.
- Can harm an unborn baby; effective contraception is recommended during treatment and for five months afterward.
Pregnancy
May cause fetal harm. Avoid pregnancy during treatment and for five months after the final dose.
Breastfeeding
It is not known whether isatuximab passes into breast milk; breastfeeding is not recommended during treatment and for five months afterward.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.